Financials
- Market Capitalization 56.3388 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
—
Relación precio/flujo de caja
—
Dividendos por acción
—
Rendimiento por dividendo, %
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4113 | GOSS Gossamer Bio, Inc. - Common Stock | 9.28 USD | -0.32% | -13.83% | -15.25% | +286.67% | 56.71 M USD | ||
| 4115 | RNXT RenovoRx, Inc. - Common Stock | 1.25 USD | -2.34% | -15.54% | -28.57% | +15.74% | 56.41 M USD | ||
| 4119 | ELOX Eloxx Pharmaceuticals, Inc. | 13.89 USD | +1.09% | -10.16% | -9.81% | +38.90% | 56.07 M USD | ||
| 4125 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | -4.21% | -32.59% | -82.43% | 54.90 M USD |